Cipla USA, Inc. v. Ipsen Biopharmaceuticals, Inc.
| Cipla USA, Inc. |
| Ipsen Biopharmaceuticals, Inc. |
| 1:2022cv00552 |
| April 28, 2022 |
| US District Court for the District of Delaware |
| Vacant Judgeship (2022) |
| Other Statutory Actions |
| 15 U.S.C. ยง 1125 Trademark Infringement (Lanham Act) |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 26, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 4 MOTION for Pro Hac Vice Appearance of Attorney Brian Burgess, Katherine Cheng, and Robert D. Carroll of Goodwin Procter LLP - filed by Cipla USA, Inc.. (Moore, David) |
| Filing 3 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent InvaGen Pharmaceuticals, Inc., Corporate Parent Cipla Limited, Corporate Parent Cipla (EU Limited) for Cipla USA, Inc. filed by Cipla USA, Inc.. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed with Jury Demand against Ipsen Biopharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3861287.) - filed by Cipla USA, Inc.. (Attachments: #1 Civil Cover Sheet)(mpb) |
| No Summons Issued. (mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
